Delve into NAFLD and metabolic dysfunction-associated steatotic liver disease (MASLD), examining pathophysiological triggers, risk of progression to cirrhosis, and evidence-based reversal strategies.
Delve into NAFLD and metabolic dysfunction-associated steatotic liver disease (MASLD), examining pathophysiological triggers, risk of progression to cirrhosis, and evidence-based reversal strategies.